Duty to Warn?—The Ethics of Disclosing Information about Possible Risks Associated with H1N1 Vaccination
Open Access
- 1 November 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 33 (11) , 1426-1427
Abstract
IN THIS ISSUE OF SLEEP A LETTER TO THE EDITOR APPEARS FROM DAUVILLIERS AND COLLEAGUES1 REPORTING A POSSIBLE ASSOCIATION BETWEEN narcolepsy-cataplexy and H1N1 exposure believed to be primarily through the vaccine Pandemrix2 (GlaxoSmithKline), which contained the adjuvant ASO39. This report follows an earlier observation of an association by Swedish authorities, which led to the suspension of the use of this vaccine in Sweden and Finland.3Keywords
This publication has 2 references indexed in Scilit:
- Post-H1N1 Narcolepsy-CataplexySLEEP, 2010
- Unlicensed pandemic influenza A H1N1 vaccinesThe Lancet, 2010